Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

66.96
+0.26000.39%
Post-market: 66.60-0.3600-0.54%19:47 EDT
Volume:11.56M
Turnover:763.14M
Market Cap:9.96B
PE:-8.75
High:67.15
Open:65.86
Low:64.27
Close:66.70
52wk High:90.75
52wk Low:39.87
Shares:148.81M
Float Shares:136.00M
Volume Ratio:1.92
T/O Rate:8.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.6496
EPS(LYR):-5.6333
ROE:-36.51%
ROA:-22.61%
PB:3.61
PE(LYR):-11.89

Loading ...

Vaxcyte files to sell $500M of common stock, $500M of convertible senior notes

TIPRANKS
·
Oct 06

Vaxcyte Shares Fall 3.5% to $71.84 After the Bell, Announced Start of Public Offering of Stock, Warrants, Convertibles

THOMSON REUTERS
·
Oct 06

Vaxcyte Launches USD 500 Million Convertible Senior Notes Offering Due 2032

Reuters
·
Oct 06

Vaxcyte, - Commences $500 Mln Common Stock and $500 Mln Convertible Notes Offerings

THOMSON REUTERS
·
Oct 06

Vaxcyte, - Proceeds to be Used for Medical Affairs and Commercial Investments for U.S. Vax-31 Launch

THOMSON REUTERS
·
Oct 06

Vaxcyte, - Proceeds to Support Manufacturing Scale-up and Potential Pcv Program Launches

THOMSON REUTERS
·
Oct 06

Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

THOMSON REUTERS
·
Oct 06

Vaxcyte, - Proceeds to Fund Clinical Development of Vax-31 Adult and Pediatric Programs

THOMSON REUTERS
·
Oct 06

Top Midday Gainers

MT Newswires Live
·
Oct 06

Needham Raises Price Target on Vaxcyte to $122 From $110, Maintains Buy Rating

MT Newswires Live
·
Oct 06

Under the Radar: Vaxcyte Stock Jumps After Pneumonia Vaccine Holds up in Study

Dow Jones
·
Oct 06

Intel, XP Inc., PTC, RXO, Vaxcyte, Western Digital, Cerebras, and More Stocks That Explain Today's Market

Dow Jones
·
Oct 06

Vaxcyte Stock Spikes 57% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck

Dow Jones
·
Oct 05

Market Movers | Vaxcyte Soars 47%; Alector Surges 32%; RXO Jumps 24%; Cerebras Rallies 8%; Critical Metals Gains 3%

Tiger Newspress
·
Oct 05

Vaxcyte rises 46.4%

TIPRANKS
·
Oct 05

Vaxcyte data hit ‘blue-sky’ case, says Jefferies

TIPRANKS
·
Oct 05

Vaxcyte can trade in $90-$100 range on data, says Mizuho

TIPRANKS
·
Oct 05

Movement Alert|Vaxcyte, Inc. Intraday Rise 53.91%, Pneumonia Vaccine Meets Phase 3 Trial Endpoints

Market Focus
·
Oct 05

Vaxcyte Shares up 57% as Pneumococcal Vaccine Meets Main Trial Goals

THOMSON REUTERS
·
Oct 05

US Opening Bell | S&P 500 edges higher; Vaxcyte, Inc. soars 53%; Biotech, chip stocks rally

US Opening Bell
·
Oct 05